Arborea: Funding, Investors & Team (Sep 2026)
Founded in 2015 by CEO Julian Melchiorri, Arborea is industrializing photosynthesis to expand the world’s food supply. The start-up has developed a breakthrough ingredients & proteins production platform that solves the crucial issues of existing photosynthetic culture platforms. Arborea’s cultivation technology for photosynthetic microorganisms mimics the functioning mechanisms of a real leaf. In doing so, it has created a radically more effective food production platform resulting in a capital-light, scalable solution which slashes the costs of fermentation. Arborea is on a mission to make healthy and sustainable food the primary choice for everyone by enabling hitherto expensive nutritional ingredients and proteins to be produced sustainably, efficiently, and affordably.
Arborea has raised $4.3M across 1 funding round on record, the most recent a Seed of $4.3M announced in Jul 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Arborea Company Profile and Key Stats
Latest funding round on record: Jul 2021.
Arborea Funding Rounds
Arborea Founders and Leadership Team
Contact details for the Arborea team: 1 of 1 has an email address on file.
Start 14-day free trial →Arborea Funding Compared to Other Biotechnology Startups
Arborea's latest round of $4.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Arborea in Biotechnology and London
Companies Similar to Arborea
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Arborea Funding FAQs
What does Arborea do?
Founded in 2015 by CEO Julian Melchiorri, Arborea is industrializing photosynthesis to expand the world’s food supply. The start-up has developed a breakthrough ingredients & proteins production platform that solves the crucial issues of existing photosynthetic culture platforms. Arborea’s cultivation technology for photosynthetic microorganisms mimics the functioning mechanisms of a real leaf. In doing so, it has created a radically more effective food production platform resulting in a capital-light, scalable solution which slashes the costs of fermentation. Arborea is on a mission to make healthy and sustainable food the primary choice for everyone by enabling hitherto expensive nutritional ingredients and proteins to be produced sustainably, efficiently, and affordably.
How much funding has Arborea raised?
Arborea has raised $4.3M across 1 round on record. The most recent is a Seed of $4.3M announced in Jul 2021.
When did Arborea last raise funding?
Arborea's most recent funding round on record is a Seed of $4.3M, announced in Jul 2021.
Who is the CEO of Arborea?
Julian Melchiorri is listed as CEO at Arborea.
Where is Arborea headquartered?
Arborea is based in London, England, United Kingdom.
How many employees does Arborea have?
Arborea is in the 1-10 employee band.
How does Arborea's funding compare to other Biotechnology startups?
Arborea's latest round of $4.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Arborea Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Arborea is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.